ALKERMES | Biaya Penjualan


Cost Of Sales Perubahan
Abbvie ABBV:US $ 4142M 121M
Acadia Pharmaceuticals ACAD:US $ 2.67M 0.28M
Acorda Therapeutics ACOR:US $ 8.8M 2.83M
Amgen AMGN:US $ 1510M 51M
Biogen BIIB:US $ 484M 269.9M
Biomarin Pharmaceutical BMRN:US $ 123.13M 6.16M
Bluebird Bio BLUE:US $ 1.74M 6.56M
Bristol Myers Squibb BMY:US $ 2677M 206M
Coherus Biosciences CHRS:US $ 11.28M 1.91M
Eli Lilly And LLY:US $ 1430.5M 641.6M
Gilead Sciences GILD:US $ 1442M 18M
Heron Therapeutics HRTX:US $ 16.18M 4.82M
Horizon Pharma HZNP:US $ 230.22M 15.15M
Intra Cellular Therapies ITCI:US $ 4.65M 1.5M
IONIS PHARMACEUT IONS:US $ 4.74M 0.57M
JAZZ PHA JAZZ:US $ 124.21M 8.92M
Johnson & Johnson JNJ:US $ 7919M 321M
Merk MRK:US $ 3698M 1636M
Nektar Therapeutics NKTR:US $ 5.12M 0.2M
Neurocrine Biosciences NBIX:US $ 4.8M 0.2M
Otsuka Holdings 4578:JP Y 147947M 21607M
Pfizer PFE:US $ 8671M 1339M
Regeneron Pharmaceuticals REGN:US $ 297.1M 107.8M
Revance Therapeutics RVNC:US $ 9.52M 1.63M
Teva Pharmaceutical Industries TEVA:US $ 1958M 99M
Vertex Pharmaceuticals VRTX:US $ 261.8M 16M



ALKERMES Biaya Penjualan - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Aug 2022.